Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates
From MaRDI portal
Publication:4485160
DOI10.1080/10273660008833040zbMath0965.92024OpenAlexW2023493258MaRDI QIDQ4485160
Peter D. Senter, James D. Murray, Trachette L. Jackson
Publication date: 7 August 2001
Published in: Journal of Theoretical Medicine (Search for Journal in Brave)
Full work available at URL: https://eudml.org/doc/230063
ordinary differential equationspartial differential equationscancer chemotherapytumor heterogeneityantibody-enzyme conjugatesprodrugs
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)
Related Items
Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model, Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites, A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
